Event Videos


A poem by Janice Raquela Mendonca



j.r.m© 2015

http://www.ncbi.nlm.nih.gov/pubmed/26499012

Billiary Atresia

Ramachandran P, Safwan M, Reddy MS, Rela M. Recent Trends in the Diagnosis and Management of Biliary Atresia in Developing Countries. Indian Pediatr. 2015 Oct8;52(10):871-9.

Abstract

NEED AND PURPOSE OF REVIEW:
Biliary atresia is a progressive obstructive cholangiopathy and is fatal if left untreated within 2 years of life. Delay in referral is because of difficulties in differentiating it from physiologic jaundice and identifying an abnormal stool color. This paper presents an overview on the diagnosis and discusses the current strategies in the management of this disease in developing countries.

METHODS:

Published on: 
Oct-2015

http://www.ncbi.nlm.nih.gov/pubmed/25708058

Malhotra S, Sibal A, Bhatia V, Kapoor A, Gopalan S, Seth S, Jerath N, Wadhawan M, Gupta S. Living Related Liver Transplantation for Biliary Atresia in the Last 5 years: Experience from the First Liver Transplant Program in India. Indian J Pediatr. 2015 Oct; 82(10):884-9.

Abstract

OBJECTIVE:
To study the clinical, biochemical profile and outcome of patients with biliary atresia (BA) who underwent living related liver transplantation (LRLT) at authors' institute in the last 5 y (2008-2013).

METHODS:
Case records of the 20 patients diagnosed with biliary atresia who had undergone living related liver transplantation at authors' centre in the last 5 y were analysed.

RESULTS:

Published on: 
Oct-2015

http://www.ncbi.nlm.nih.gov/pubmed/26049707

Korkmaz H, Unler GK, Gokturk HS, Schmidt WE, Kebapcilar L. Noninvasive estimation of disease activity and liver fibrosis in nonalcoholic fatty liver disease using anthropometric and biochemical characteristics, including insulin, insulin resistance, and 13C-methionine breath test. Eur J Gastroenterol Hepatol. 2015 Oct; 27(10):1137-43.

Abstract

OBJECTIVE:
The purpose of this study was to noninvasively estimate disease activity and liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) using anthropometric and biochemical characteristics and the C-methionine breath test (MeBT).

METHODS:

Published on: 
Oct-2015

http://www.ncbi.nlm.nih.gov/pubmed/25557177

Alam S, Lal BB, Khanna R, Sood V, Rawat D. Acute Liver Failure in Infants and Young Children in a Specialized Pediatric Liver Centre in India. Indian J Pediatr. 2015 Oct; 82(10):879-83.

Abstract

OBJECTIVE:
To study the etiological spectrum of acute liver failure in infants and young children and to identify clinical and biochemical markers for metabolic liver disease (MLD).

METHODS:

Published on: 
Oct-2015

http://www.ncbi.nlm.nih.gov/pubmed/26062080

Abdel-Ghaffar TY, Sira MM, Sira AM, Salem TA, El-Sharawy AA, El Naghi S. Serological markers of autoimmunity in children with hepatitis A: relation to acute and fulminant presentation. Eur J Gastroenterol Hepatol. 2015 Oct; 27(10):1161-9

Abstract

OBJECTIVES:
Hepatitis A virus (HAV) infection tends to be a self-limiting disease without serious sequelae, but fulminant hepatitis, with a high mortality, develops in 0.1-0.2% of the cases. Sometimes, HAV infection precipitates autoimmune hepatitis (AIH). We aimed to assess the frequency and clinical significance of serologic markers of autoimmunity during hepatitis A infection with an acute or fulminant presentation compared with those in AIH.

METHODS:

Published on: 
Oct-2015

http://www.ncbi.nlm.nih.gov/pubmed/25988560

Heshin-Bekenstein M, Turner D, Shamir R, Bar-Meir M, Dagan R, Zevit N, Silbermintz A. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease. J Pediatr Gastroenterol Nutr. 2015 Oct; 61(4):400-3.

Abstract

OBJECTIVE:
Previous studies have suggested that hepatitis B virus (HBV) vaccines may be less immunogenic in individuals with celiac disease (CD). A pre-S vaccine (Sci-B-Vac) has demonstrated superior immunogenicity compared with standard HBV vaccines in several diseases. We compared the short-term immunogenicity of a pre-S vaccine with a HBV vaccine (Engerix B) for repeat vaccination of seronegative, previously immunized patients with CD.

METHODS:

Published on: 
Oct-2015

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: